Cargando…
Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global public health crisis. Effective COVID-19 vaccines developed by Pfizer-BioNTech, Moderna, and Astra Zeneca have made significant impacts in controlling the COVID-19 burden, especially in reducing the transmission of SARS...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029629/ https://www.ncbi.nlm.nih.gov/pubmed/35457159 http://dx.doi.org/10.3390/ijms23084341 |
_version_ | 1784691926735257600 |
---|---|
author | Lim, Hui Xuan Masomian, Malihe Khalid, Kanwal Kumar, Asqwin Uthaya MacAry, Paul A. Poh, Chit Laa |
author_facet | Lim, Hui Xuan Masomian, Malihe Khalid, Kanwal Kumar, Asqwin Uthaya MacAry, Paul A. Poh, Chit Laa |
author_sort | Lim, Hui Xuan |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global public health crisis. Effective COVID-19 vaccines developed by Pfizer-BioNTech, Moderna, and Astra Zeneca have made significant impacts in controlling the COVID-19 burden, especially in reducing the transmission of SARS-CoV-2 and hospitalization incidences. In view of the emergence of new SARS-CoV-2 variants, vaccines developed against the Wuhan strain were less effective against the variants. Neutralizing antibodies produced by B cells are a critical component of adaptive immunity, particularly in neutralizing viruses by blocking virus attachment and entry into cells. Therefore, the identification of protective linear B-cell epitopes can guide epitope-based peptide designs. This study reviews the identification of SARS-CoV-2 B-cell epitopes within the spike, membrane and nucleocapsid proteins that can be incorporated as potent B-cell epitopes into peptide vaccine constructs. The bioinformatic approach offers a new in silico strategy for the mapping and identification of potential B-cell epitopes and, upon in vivo validation, would be useful for the rapid development of effective multi-epitope-based vaccines. Potent B-cell epitopes were identified from the analysis of three-dimensional structures of monoclonal antibodies in a complex with SARS-CoV-2 from literature mining. This review provides significant insights into the elicitation of potential neutralizing antibodies by potent B-cell epitopes, which could advance the development of multi-epitope peptide vaccines against SARS-CoV-2. |
format | Online Article Text |
id | pubmed-9029629 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90296292022-04-23 Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting Lim, Hui Xuan Masomian, Malihe Khalid, Kanwal Kumar, Asqwin Uthaya MacAry, Paul A. Poh, Chit Laa Int J Mol Sci Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global public health crisis. Effective COVID-19 vaccines developed by Pfizer-BioNTech, Moderna, and Astra Zeneca have made significant impacts in controlling the COVID-19 burden, especially in reducing the transmission of SARS-CoV-2 and hospitalization incidences. In view of the emergence of new SARS-CoV-2 variants, vaccines developed against the Wuhan strain were less effective against the variants. Neutralizing antibodies produced by B cells are a critical component of adaptive immunity, particularly in neutralizing viruses by blocking virus attachment and entry into cells. Therefore, the identification of protective linear B-cell epitopes can guide epitope-based peptide designs. This study reviews the identification of SARS-CoV-2 B-cell epitopes within the spike, membrane and nucleocapsid proteins that can be incorporated as potent B-cell epitopes into peptide vaccine constructs. The bioinformatic approach offers a new in silico strategy for the mapping and identification of potential B-cell epitopes and, upon in vivo validation, would be useful for the rapid development of effective multi-epitope-based vaccines. Potent B-cell epitopes were identified from the analysis of three-dimensional structures of monoclonal antibodies in a complex with SARS-CoV-2 from literature mining. This review provides significant insights into the elicitation of potential neutralizing antibodies by potent B-cell epitopes, which could advance the development of multi-epitope peptide vaccines against SARS-CoV-2. MDPI 2022-04-14 /pmc/articles/PMC9029629/ /pubmed/35457159 http://dx.doi.org/10.3390/ijms23084341 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lim, Hui Xuan Masomian, Malihe Khalid, Kanwal Kumar, Asqwin Uthaya MacAry, Paul A. Poh, Chit Laa Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting |
title | Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting |
title_full | Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting |
title_fullStr | Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting |
title_full_unstemmed | Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting |
title_short | Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting |
title_sort | identification of b-cell epitopes for eliciting neutralizing antibodies against the sars-cov-2 spike protein through bioinformatics and monoclonal antibody targeting |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029629/ https://www.ncbi.nlm.nih.gov/pubmed/35457159 http://dx.doi.org/10.3390/ijms23084341 |
work_keys_str_mv | AT limhuixuan identificationofbcellepitopesforelicitingneutralizingantibodiesagainstthesarscov2spikeproteinthroughbioinformaticsandmonoclonalantibodytargeting AT masomianmalihe identificationofbcellepitopesforelicitingneutralizingantibodiesagainstthesarscov2spikeproteinthroughbioinformaticsandmonoclonalantibodytargeting AT khalidkanwal identificationofbcellepitopesforelicitingneutralizingantibodiesagainstthesarscov2spikeproteinthroughbioinformaticsandmonoclonalantibodytargeting AT kumarasqwinuthaya identificationofbcellepitopesforelicitingneutralizingantibodiesagainstthesarscov2spikeproteinthroughbioinformaticsandmonoclonalantibodytargeting AT macarypaula identificationofbcellepitopesforelicitingneutralizingantibodiesagainstthesarscov2spikeproteinthroughbioinformaticsandmonoclonalantibodytargeting AT pohchitlaa identificationofbcellepitopesforelicitingneutralizingantibodiesagainstthesarscov2spikeproteinthroughbioinformaticsandmonoclonalantibodytargeting |